联合化学 (301209.SZ) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	512.2M	512.1M	534.6M	428.4M	542.0M
Cost of Revenue	407.4M	409.2M	432.4M	361.6M	448.4M
Gross Profit	104.8M	102.9M	102.2M	66.8M	93.6M
Operating Expenses
R&D Expense	21.5M	22.6M	24.2M	19.0M	21.8M
SG&A Expense	—	—	—	—	—
General & Admin Expense	15.9M	15.9M	14.3M	12.4M	15.3M
Selling & Marketing Expense	6.2M	6.1M	6.3M	4.7M	4.7M
Other Expenses	—	—	—	—	—
Total Operating Expenses	49.1M	45.9M	37.1M	30.9M	35.9M
Cost and Expenses	456.5M	455.1M	469.6M	392.5M	484.2M
Operating Income (EBIT)	47.3M	59.5M	66.5M	38.4M	71.4M
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	—	—	—	—	—
Net Interest Income	—	—	—	—	—
Other Non-Op Income/Expense	—	—	—	—	—
Non-Operating Income (excl Interest)	—	—	—	—	—
EBT (Pre-Tax Income)	46.9M	59.3M	63.6M	37.7M	70.9M
Income Tax Expense	6.5M	6.7M	7.2M	3.8M	6.7M
Bottom Line
Net Income	40.6M	52.6M	56.4M	33.8M	64.2M
Earnings from Cont. Ops	40.5M	52.6M	56.4M	33.8M	64.2M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	40.6M	52.6M	56.4M	33.8M	64.2M
Per Share
Basic EPS	CN¥0.36	CN¥0.47	CN¥0.50	CN¥0.42	CN¥0.96
Diluted EPS	CN¥0.36	CN¥0.47	CN¥0.50	CN¥0.42	CN¥0.96
Revenue Per Share	CN¥4.57	CN¥4.57	CN¥4.77	CN¥5.36	CN¥8.13
Shares
Basic Shares Outstanding	112.1M	112.0M	112.0M	80.0M	66.7M
Diluted Shares Outstanding	112.1M	112.0M	112.0M	80.0M	66.7M
Profitability Metrics
EBITDA	—	75.6M	81.8M	53.2M	84.7M
D&A	—	16.1M	15.4M	14.8M	13.3M
EBIT	—	—	—	—	—

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026